al. reported that grade ≥3 neutropenia occurred more frequently in patients who were heterozygous for UGT1A1*6 allele, while not for *28 allele in gastric cancer patients treated with nal-IRI [29]. The gene discussed is UGT1A1; the disease is neutropenia.